Discovery of a Non-Peptidic Inhibitor of West Nile Virus NS3 Protease by High-Throughput Docking

被引:62
作者
Ekonomiuk, Dariusz [1 ]
Su, Xun-Cheng [2 ]
Ozawa, Kiyoshi [2 ]
Bodenreider, Christophe [3 ]
Lim, Siew Pheng [3 ]
Yin, Zheng [3 ]
Keller, Thomas H. [3 ]
Beer, David [3 ]
Patel, Viral [3 ]
Otting, Gottfried [2 ]
Caflisch, Amedeo [1 ]
Huang, Danzhi [1 ]
机构
[1] Univ Zurich, Dept Biochem, Zurich, Switzerland
[2] Australian Natl Univ, Res Sch Chem, Canberra, ACT, Australia
[3] Novartis Inst Trop Dis, Chromos, Singapore
关键词
HEPATITIS-C-VIRUS; ORBITAL ELECTRONEGATIVITY METHOD; MODIFIED PARTIAL EQUALIZATION; SERINE-PROTEASE; ANTIVIRAL ACTIVITY; PEPTIDE INHIBITORS; INTERACTION ENERGIES; BETA-SECRETASE; BINDING; POTENT;
D O I
10.1371/journal.pntd.0000356
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Background: The non-structural 3 protease (NS3pro) is an essential flaviviral enzyme and therefore one of the most promising targets for drug development against West Nile virus (WNV) and dengue infections. Methodology: In this work, a small-molecule inhibitor of the WNV NS3pro has been identified by automatic fragment-based docking of about 12000 compounds and testing by nuclear magnetic resonance (NMR) spectroscopy of only 22 molecules. Specific binding of the inhibitor into the active site of NS3pro and its binding mode are confirmed by N-15-HSQC NMR spectra. The inhibitory activity is further validated by an enzymatic assay and a tryptophan fluorescence quenching assay. Conclusion: The inhibitor [4-(carbamimidoylsulfanylmethyl)-2,5-dimethylphenyl]-methylsulfanylmethanimidamide has a good ratio of binding affinity versus molecular weight ( ligand efficiency of 0.33 kcal/mol per non-hydrogen atom), and thus has good potential as lead compound for further development to combat West Nile virus infections.
引用
收藏
页数:9
相关论文
共 67 条
[41]   A structural perspective of the Flavivirus life cycle [J].
Mukhopadhyay, S ;
Kuhn, RJ ;
Rossmann, MG .
NATURE REVIEWS MICROBIOLOGY, 2005, 3 (01) :13-22
[42]   Potent triazolyl-proline-based inhibitors of HCVNS3 protease [J].
Naud, Julie ;
Lemke, Christopher ;
Goudreau, Nathalie ;
Beaulieu, Eric ;
White, Peter D. ;
Llinas-Brunet, Montse ;
Forgione, Pat .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2008, 18 (11) :3400-3404
[43]   DETERMINATION OF NET ATOMIC CHARGES USING A MODIFIED PARTIAL EQUALIZATION OF ORBITAL ELECTRONEGATIVITY METHOD .2. APPLICATION TO IONIC AND AROMATIC-MOLECULES AS MODELS FOR POLYPEPTIDES [J].
NO, KT ;
GRANT, JA ;
JHON, MS ;
SCHERAGA, HA .
JOURNAL OF PHYSICAL CHEMISTRY, 1990, 94 (11) :4740-4746
[44]   DETERMINATION OF NET ATOMIC CHARGES USING A MODIFIED PARTIAL EQUALIZATION OF ORBITAL ELECTRONEGATIVITY METHOD .1. APPLICATION TO NEUTRAL MOLECULES AS MODELS FOR POLYPEPTIDES [J].
NO, KT ;
GRANT, JA ;
SCHERAGA, HA .
JOURNAL OF PHYSICAL CHEMISTRY, 1990, 94 (11) :4732-4739
[45]   Preclinical profile of VX-950, a potent, selective, and orally bioavailable inhibitor of hepatitis C virus NS3-4A serine protease [J].
Perni, RB ;
Almquist, SJ ;
Byrn, RA ;
Chandorkar, G ;
Chaturvedi, PR ;
Courtney, LF ;
Decker, CJ ;
Dinehart, K ;
Gates, CA ;
Harbeson, SL ;
Heiser, A ;
Kalkeri, G ;
Kolaczkowski, E ;
Lin, K ;
Luong, YP ;
Rao, BG ;
Taylor, WP ;
Thomson, JA ;
Tung, RD ;
Wei, YY ;
Kwong, AD ;
Lin, C .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2006, 50 (03) :899-909
[46]   Discovery of the HCVNS3/4A protease inhibitor (1R,5S)-N-[3-amino-1-(cyclobutylmethyl)-2,3-dioxopropyl]-3-[2(S)-[[[(1,1-dimethylethyl)amino]carbonyl]amino]-3,3-dimethyl-1-oxobutyl]-6,6-dimethyl-3-azabicyclo[3.1.0]hexan-2(S)-carboxamide (Sch 503034) II.: Key steps in structure-based optimization [J].
Prongay, Andrew J. ;
Guo, Zhuyan ;
Yao, Nanhua ;
Pichardo, John ;
Fischmann, Thierry ;
Strickland, Corey ;
Myers, Joseph, Jr. ;
Weber, Patricia C. ;
Beyer, Brian M. ;
Ingram, Richard ;
Hong, Zhi ;
Prosise, Winifred W. ;
Ramanathan, Lata ;
Taremi, S. Shane ;
Yarosh-Tomaine, Taisa ;
Zhang, Rumin ;
Senior, Mary ;
Yang, Rong-Sheng ;
Malcolm, Bruce ;
Arasappan, Ashok ;
Bennett, Frank ;
Bogen, Stephane L. ;
Chen, Kevin ;
Jao, Edwin ;
Liu, Yi-Tsung ;
Lovey, Raymond G. ;
Saksena, Anil K. ;
Venkatraman, Srikanth ;
Girijavallabhan, Viyyoor ;
Njoroge, F. George ;
Madison, Vincent .
JOURNAL OF MEDICINAL CHEMISTRY, 2007, 50 (10) :2310-2318
[47]   Structure-activity relationship study on a novel series of cyclopentane-containing macrocyclic inhibitors of the hepatitis C virus NS3/4A protease leading to the discovery of TMC435350 [J].
Raboisson, Pierre ;
de Kock, Herman ;
Rosenquist, Asa ;
Nilsson, Magnus ;
Salvador-Oden, Lourdes ;
Lin, Tse-I ;
Roue, Natalie ;
Ivanov, Vladimir ;
Wahling, Horst ;
Wickstrom, Kristina ;
Hamelink, Elizabeth ;
Edlund, Michael ;
Vrang, Lotta ;
Vendeville, Sandrine ;
Van de Vreken, Wim ;
McGowan, David ;
Tahri, Abdellah ;
Hu, Lili ;
Boutton, Carlo ;
Lenz, Oliver ;
Delouvroy, Frederic ;
Pille, Geert ;
Surleraux, Dominique ;
Wigerinck, Piet ;
Samuelsson, Bertil ;
Simmen, Kenneth .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2008, 18 (17) :4853-4858
[48]   Discovery of novel potent and selective dipeptide hepatitis C virus NS3/4A serine protease inhibitors [J].
Raboisson, Pierre ;
Lin, Tse-I ;
de Kock, Herman ;
Vendeville, Sandrine ;
de Vreken, Wim Van ;
McGowan, David ;
Tahri, Abdellah ;
Hu, Lili ;
Lenz, Oliver ;
Delouvroy, Frederic ;
Surleraux, Dominique ;
Wigerinck, Piet ;
Nilsson, Magnus ;
Rosenquist, Asa ;
Samuelsson, Bertil ;
Simmen, Kenneth .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2008, 18 (18) :5095-5100
[49]   Synthesis, antiviral activity, and conformational studies of a P3 aza-peptide analog of a potent macrocyclic tripeptide HCV protease inhibitor [J].
Randolph, John T. ;
Zhang, Xiaolin ;
Huang, Peggy P. ;
Klein, Larry L. ;
Kurtz, Kevin A. ;
Konstantinidis, Alex K. ;
He, Wenping ;
Kati, Warren M. ;
Kempf, Dale J. .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2008, 18 (08) :2745-2750
[50]   Continuum electrostatic energies of macromolecules in aqueous solutions [J].
Scarsi, M ;
Apostolakis, J ;
Caflisch, A .
JOURNAL OF PHYSICAL CHEMISTRY A, 1997, 101 (43) :8098-8106